Javascript must be enabled to continue!
Different vessel response between chronic total occlusions and non-CTO lesion after Sirolimus-eluting stent implantation: a serial optical coherence tomography study
View through CrossRef
Objectives
To investigate the neointimal coverage and malapposition of sirolimus-eluting stent in treatment of CTOs and non-CTO lesions (including lipid-rich plaque and non-lipid-rich plaque) by optical coherence tomography.
Methods
We enrolled 64 patients (CTO: n=29 stents/21 patients, lipid-rich plaque: n=33 stents/26 patients, and non-lipid-rich plaque: n=21 stents/17 patients) with 68 target vessels and examined lesion characteristics by using OCT at pre- and post-SES implantation and 6 months follow-up. Lipid rich plaque was defined as the plaque with lipid content in ≥2 quadrants. Non-lipid-rich plaque consists of fibrous, fibrocalcific plaque, and lipid plaque with less than two quadrants lipid content.
Results
The incidence of incomplete stent apposition was higher in CTO and lesion with lipid rich plaque compared with those with non-lipid rich plaque (3.03%, 2.58% vs 0.64%, p=0.0219). The tissue protrusion (14.99 % vs 11.00% vs 6.41%, p<0.001) and intra-stent thrombus (3.81% vs 2.39% vs 1.07%, p=0.0119) after percutaneous coronary intervention were observed most frequently in lipid-rich plaque group then followed by those in CTO group and non-lipid rich plaque group. At 6 months follow-up, the incidence of malapposition (5.0% vs 1.04% and 0.4%, p=0.002), the cross section with uncovered struts (23.4% vs 8.2% and 6.6%, p<0.001), and protrusion (30.8% vs 9.6% and 9.6%, p<0.001) was significantly greater in patients with CTO than those with lipid rich plaque and non-lipid rich plaque. Although the incidence of in-stent thrombus was non-significantly higher in CTO than LRP and non-LRP (9.4% vs 3.1% vs 0%, p=0.26), there was no adverse event in these patients with CTO.
Conclusions
Initial lesion morphology is contributable to coronary artery response to DES after stent implantation. CTOs and lipid rich plaque is associated with higher incidence of malapposition, tissue protrusion, and mural thrombus after stenting. At 6 months follow-up, the vessels with CTO lesions were characterised by delayed healing and higher incidence of malapposition.
Title: Different vessel response between chronic total occlusions and non-CTO lesion after Sirolimus-eluting stent implantation: a serial optical coherence tomography study
Description:
Objectives
To investigate the neointimal coverage and malapposition of sirolimus-eluting stent in treatment of CTOs and non-CTO lesions (including lipid-rich plaque and non-lipid-rich plaque) by optical coherence tomography.
Methods
We enrolled 64 patients (CTO: n=29 stents/21 patients, lipid-rich plaque: n=33 stents/26 patients, and non-lipid-rich plaque: n=21 stents/17 patients) with 68 target vessels and examined lesion characteristics by using OCT at pre- and post-SES implantation and 6 months follow-up.
Lipid rich plaque was defined as the plaque with lipid content in ≥2 quadrants.
Non-lipid-rich plaque consists of fibrous, fibrocalcific plaque, and lipid plaque with less than two quadrants lipid content.
Results
The incidence of incomplete stent apposition was higher in CTO and lesion with lipid rich plaque compared with those with non-lipid rich plaque (3.
03%, 2.
58% vs 0.
64%, p=0.
0219).
The tissue protrusion (14.
99 % vs 11.
00% vs 6.
41%, p<0.
001) and intra-stent thrombus (3.
81% vs 2.
39% vs 1.
07%, p=0.
0119) after percutaneous coronary intervention were observed most frequently in lipid-rich plaque group then followed by those in CTO group and non-lipid rich plaque group.
At 6 months follow-up, the incidence of malapposition (5.
0% vs 1.
04% and 0.
4%, p=0.
002), the cross section with uncovered struts (23.
4% vs 8.
2% and 6.
6%, p<0.
001), and protrusion (30.
8% vs 9.
6% and 9.
6%, p<0.
001) was significantly greater in patients with CTO than those with lipid rich plaque and non-lipid rich plaque.
Although the incidence of in-stent thrombus was non-significantly higher in CTO than LRP and non-LRP (9.
4% vs 3.
1% vs 0%, p=0.
26), there was no adverse event in these patients with CTO.
Conclusions
Initial lesion morphology is contributable to coronary artery response to DES after stent implantation.
CTOs and lipid rich plaque is associated with higher incidence of malapposition, tissue protrusion, and mural thrombus after stenting.
At 6 months follow-up, the vessels with CTO lesions were characterised by delayed healing and higher incidence of malapposition.
Related Results
Crush Stenting With Paclitaxel-Eluting or Sirolimus-Eluting Stents for the Treatment of Coronary Bifurcation Lesions
Crush Stenting With Paclitaxel-Eluting or Sirolimus-Eluting Stents for the Treatment of Coronary Bifurcation Lesions
Two hundred forty-six patients with 252 bifurcation lesions were enrolled into a prospective, nonrandomized study to use paclitaxel-eluting or sirolimus-eluting stent for crush ste...
CLINICAL APPLICATION OF DOMESTIC LONG BIODEGRADABLE POLYMER COATED SIROLIMUS ELUTING STENTS FOR TREATMENT OF LONG CORONARY ARTERY LESIONS
CLINICAL APPLICATION OF DOMESTIC LONG BIODEGRADABLE POLYMER COATED SIROLIMUS ELUTING STENTS FOR TREATMENT OF LONG CORONARY ARTERY LESIONS
Objectives
To evaluate the efficacy and safety of domestic long biodegradable polymer coated sirolimus eluting stents (Excel stent, Shandong JW) for treatment of ...
Abstract 16621: Factors Influencing the Difficulty of Guidewire Passage in Duplex-Guided Endovascular Treatment for Femoropopliteal Chronic Total Occlusions
Abstract 16621: Factors Influencing the Difficulty of Guidewire Passage in Duplex-Guided Endovascular Treatment for Femoropopliteal Chronic Total Occlusions
Introduction:
Previous studies have shown the effectiveness of duplex-guided endovascular treatment (EVT) for femoropopliteal chronic total occlusions (FP-CTO). However...
Predictors of insistent restenosis in patients undergoing percutaneous intervention
Predictors of insistent restenosis in patients undergoing percutaneous intervention
Coronary artery disease is one of the leading causes of morbidity and mortality worldwide. The first percutaneous coronary intervention was performed by Andreas Gruntzig on Septemb...
Effects of PIP targeting LOX-1 eluting stents on in-stent restenosis and re-endothelialisation in rat abdominal aorta stenting models
Effects of PIP targeting LOX-1 eluting stents on in-stent restenosis and re-endothelialisation in rat abdominal aorta stenting models
Background and Objectives
Pyrrole-Imidazole polyamide (PIP) is a novel gene silencer that can be readily designed and synthesised to target any gene. Contrary to ...
Effectiveness and safety of the sirolimus‐eluting stents coated with bioabsorbable polymer coating in human coronary arteries
Effectiveness and safety of the sirolimus‐eluting stents coated with bioabsorbable polymer coating in human coronary arteries
AbstractBackground: Although the sirolimus‐eluting stent (CYPHER®, Cordis, USA) has shown a dramatic reduction of restenosis, there are still some concerns about its efficacy and s...
Incidence and Management of In-Stent Restenosis in Patients with Drug-Eluting Stents
Incidence and Management of In-Stent Restenosis in Patients with Drug-Eluting Stents
Introduction: The most prevalent complication of cardiac intervention is restenosis. After the BMS period, drug-eluting stents (DES) are the most suitable choice for stenosis treat...
Case Report: An innovative approach to coronary artery perforation in chronic total occlusion using autologous flaps
Case Report: An innovative approach to coronary artery perforation in chronic total occlusion using autologous flaps
BackgroundA percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) carries a significant risk of coronary artery perforation (CAP). The typical treatment for pr...

